Pneumococcal vaccine shows high efficacy rate

11/16/2012 | PhysiciansBriefing.com

A pediatric study of the pneumococcal vaccine PHiD-CV10 showed efficacy rates of 100% and 92% for the 3+1 and 2+1 vaccination schedules, respectively. "For the first time, effectiveness of a 2+1 schedule in infants was confirmed in a clinical trial," Finnish researchers reported in the journal The Lancet.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY